We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiographic Scale Helps Diagnose Necrotizing Enterocolitis

By HospiMedica International staff writers
Posted on 12 Nov 2009
A new study describes a radiographic assessment scale developed to help clinicians predict disease severity in infants with necrotizing enterocolitis (NEC).

Researchers at Duke University Medical Center (Duke, Durham, NC, USA) developed the Duke abdominal assessment scale (DAAS) radiographic scale, a standardized 10-point radiographic scale that increases with disease severity; for every one point increase in the DAAS score, patients are more likely to have severe disease, and are more likely to need a surgical intervention. More...
To validate the scale, the researchers performed a case-control study of 43 infants to assess whether the DAAS scale could serve as a clinically useful tool; a control group consisted of 86 patients with suspected NEC who did not undergo surgery. The DAAS scores were assigned by two pediatric radiologists with 20 and 6 years' experience. The researchers found that patients with higher DAAS scores were more likely to undergo surgical intervention than patients with lower scores are. An analysis showed good overall performance for predicting eventual surgical intervention in the study group with higher DAAS scores. The study was published in the November 2009 issue of the American Journal of Roentgenology (AJR).

"Our study suggests that using the DAAS score when interpreting abdominal X-rays in neonates and infants with clinically suspected NEC may help guide increased level of clinical concern and monitoring for advanced NEC,” said lead author Caroline Hollingsworth, M.D. "Radiographic monitoring of disease progression and heightened clinical awareness through improved communication via the DAAS system has been a tremendous help to our clinicians at Duke.”

NEC is a serious disease that causes infection and inflammation of the intestines in infants, primarily those that are premature. Its cause is unknown, however, it is one of the leading causes of surgical intervention in preemies and has a death rate of 25%. Radiographic signs of NEC include dilated bowel loops, paucity of gas, a "fixed loop" (unaltered gas-filled loop of bowel), portal venous gas, and pneumoperitoneum (extraluminal or "free air" outside the bowel within the abdomen); the pathognomic finding on plain films is pneumatosis intestinalis.

Related Links:

Duke University Medical Center


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.